Specialty Pharmacy

Promoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.

In a phase 3 clinical trial, oral paclitaxel was found to be just as effective intravenous paclitaxel in metastatic breast cancer.

Pharmacy Times spoke with Russell Procopio, executive vice president of Long-Term Care Pharmacy, about a new study regarding long-term care outcomes and cost.

The goals of specialty pharmacy programs are to reduce or delay progression of the disease, improve patient outcomes, enhance patients’ quality of life, keep patients in the workforce longer, and decrease total health care costs.

According to results from a recent study, a functional cure for HIV may lie in identifying the viral reservoirs in which HIV places copies of its viral genetic material into cell genomes.

The current study found no link between personal use of permanent hair dye and the risk of most cancers or cancer-related mortality.

The FDA also granted priority review to pralsetinib for the treatment of patients with advanced or metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer.

Study suggests up to 75% of online pharmacies are illegitimate and pose serious health concerns.

Azacitidine showed an overall survival benefit among patients with acute myeloid leukemia compared with a placebo.

Oral chemotherapy may be an important option for patients during the COVID-19 pandemic, as it would allow them to receive treatment at home.

Women who typically have a better prognosis in the primary breast cancer setting experienced worse survival after a second primary breast cancer.

Evolocumab in combination with statins and other lipid-lowering therapies was found to significantly reduce low-density lipoprotein cholesterol in pediatric patients with heterozygous familial hypercholesterolemia.

Despite improvements in the understanding and treatment of chemotherapy-induced nausea and vomiting (CINV), nausea and emesis continue to be a distressing adverse event for patients.

Millions of Americans have vision impairments and ensuring their access to websites is not only important for their health but is also a good business practice.

A new medication for certain rare blood cancers has now become available through a limited distribution with AllianceRx Walgreens Prime.

The FDA has approved a liquid biopsy test for all solid tumors with multiple companion diagnostic indications, including for rucaparib tablets.

Targeted radiotherapy amounted to fewer deaths over a 5-year follow-up period among patients with breast cancer.

Researchers have found that gene expression associated with aging was higher in young cancer survivors who are frail and in young patients with cancer following their treatment with chemotherapy.

PTCE, the industry-leading continuing pharmacy education provider, becomes sole provider for association’s 3 major meetings through 2021.

Targeted combination therapy found to improve overall survival with rapid and durable treatment responses in patients with acute myeloid leukemia.

The 11th annual national awards program will take place online this year and recognize 30 exceptional pharmacy professionals in 10 categories

In addition to clinical procedures, some support groups for patients with breast cancer were also canceled as a result of the COVID-19 pandemic.

The researchers found that an ILI aimed at weight loss lowered incidence of obesity-related cancers by 16% in adults with overweight or obesity and T2D

An online survey found that 44% of breast cancer survivors had care delayed during the COVID-19 pandemic.

When telehealth is part of a larger personalized care plan tied specifically to a particular specialty drug, pharmacists can be better positioned to empower their patients.

Following the expansion of Medicaid coverage under the Affordable Care Act, individuals with low income are less likely to be diagnosed with advanced cancer.

The new analysis of the 23-year follow-up results of the trial found that screening women between 40 and 49 years of age led to a substantial and significant 25% reduction in breast cancer mortality in the first 10 years.

The FDA has approved an expansion of the prescribing information for carfilzomib to include its use with daratumumab and dexamethasone for the treatment of relapsed or refractory multiple myeloma.

Because triple-negative breast cancer does not express receptors involved in most breast cancers, the investigative therapy could offer a much-needed option.

Irritable bowel disease, such as ulcerative colitis and Crohn disease, can increase the risk of both cancer and death.